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Introduction 
There is much to celebrate in the increasingly successful management of complicated 
monochorionic (MC) multiple pregnancies over the last three decades. Advances in 
understanding the unique placental architecture and physiology of MC pregnancies1 has 
been translated into improved clinical management and ever increasing survival even in 
complicated MC pregnancies.2 Fetoscopic laser treatment has become standard in the 
management of twin-to-twin transfusion syndrome (TTTS)3, the distinct pathological 
condition of the twin-anaemia-polycythaemia sequence (TAPS) has been described and 
management reported4 and the classification of selective fetal growth restriction (sFGR)5 has 
facilitated improved counselling and directed intervention to the highest risk of these 
pregnancies.  
Even so, there persists a glaring research gap that is of increasing concern to clinicians and 
families. Beyond survival, what matters most to parents is the health and quality of life their 
child or children will have,6 and yet there is significant under reporting of long term outcomes 
in studies of multiple pregnancies.7 In making clinical decisions during the care of a 
complicated MC pregnancy the interests of multiple fetuses and their mother are not 
necessarily aligned, and parents want to know not only how to give their children the best 
chance at life, but life in all its fullness. As multiple pregnancies continue to increase in 
frequency8 the impact of multiple pregnancy on neonatal and infant health outcomes and 
resource use will increase in tandem. As yet we are poorly equipped to counsel families on 
the best way to optimise long term life and health for families after a multiple pregnancy, 
especially MC pregnancies.  
What do we know already and where are there gaps in the literature?  
We do know that children born after a multiple pregnancy exhibit differences in 
neurodevelopment to their singleton counterparts and that these differences can be related 
to chorionicity, complications during pregnancy and fetal number.5 Large cohort studies have 
demonstrated that MC multiples are at greater risk of cerebral palsy and 
neurodevelopmental impairment (NDI) (Figure 1) than dichorionic multiples,9,10 although all 
are at greater risk than singletons.11 Higher order multiples are at increased risk compared to 
age and gestation matched twins, although the data here is even more limited.12,13 
Neurodevelopmental impairment in uncomplicated MC pregnancies  
The prevailing assumption is that the majority of the NDI observed in multiple pregnancy is 
due to increased iatrogenic and spontaneous preterm birth, with the additional contribution of 
the special complications of monochorionicity. Around 60% of MC pregnancies will deliver 
close to term without TTTS, sFGR, TAPS, congenital anomalies or stillbirth (Figure 2).14 The 
prognosis for these babies is usually given as good. There is, however, evidence that even 
uncomplicated MC pregnancies are associated with an increase in long term NDI. Using a 
stricter definition of NDI, NDI has been identified in 7% of children after uncomplicated MC 
pregnancies.14 In this group, half of all the children with NDI were from the group of 
uncomplicated MC pregnancies born >32 weeks gestation, including one child with cerebral 
palsy. While long term pediatric follow up of extremely preterm infants is common, MC 
babies delivered at or close to term are unlikely to receive specialist follow up in many 
healthcare systems and the incidence of milder impairments may be under reported.  
Long term outcomes after complicated MC pregnancies  
The most significant predictor of NDI in MC pregnancies remains the occurrence of MC 
specific complications including TTTS, sFGR, TAPS and monoamniotic (MCMA) pregnancy. 
The complications of monochorionicity increase the risk of NDI to variable degrees, with the 
highest risk being associated with acute perimortem TTTS (Figure 3). Of note, more data is 
needed to establish whether this risk varies with gestational age, which would determine the 
optimal timing of delivery in complicated MC twin pregnancies. 
In the era of fetoscopic selective laser coagulation (FSLC) long term outcomes after TTTS in 
particular are continuing to improve.2 Increasing survival has been linked to improvements in 
surgical technique and instruments, the learning curve as more fetal surgeons acquire 
significant experience of fetoscopic interventions, improved detection and referral of high risk 
pregnancies and improvements in neonatal unit (NNU) care.15 After laser treatment, the risk 
of severe NDI has nowadays decreased  to 3-6% of surviving children,2 with mild NDI in up 
to 23%.2 Of children with NDI after TTTS treated by FSLC, 35% are delivered >32 weeks 
without evidence of cerebral injury on perinatal imaging,2 highlighting the key importance of 
longer term follow up even for lower risk babies. The most significant contributors to adverse 
outcome remain intra-uterine demise and spontaneous preterm birth after FSLC. Despite the 
several large clinical trials of FSLC in TTTS and many large observational cohorts reported, 
long term outcomes are rarely reported in the literature,16 yet when key stakeholders worked 
to agree the core outcomes of highest priority for investigators working on improving 
treatment of TTTS, neurological development at 18-24 months was prioritised.17 Importantly, 
long-term follow-up should not stop at 2 years of age, but should ideally continue until at 
least school age as some impairment (mainly mental and behavioural impairments) cannot 
always be detected at younger age and often only become more apparent later on in life.  
In TAPS, the long term outcomes include NDI in 30% of survivors, with the donor affected 
more frequently than the recipient.18 The treatment of TAPS varies widely between fetal 
therapy centres,19 with the role of FSLC not yet demonstrated in clinical trials. The 
development and validation of intervention protocols in TAPS is likely to lead to improvement 
in perinatal and long term outcomes, but this cannot be demonstrated if they are not 
measured. Importantly, 1 in 8 TAPS donors have bilateral deafness. Early detection and 
prompt intervention with hearing amplification devices is of paramount importance to 
stimulate language development and reduce the risk of speech delay.18  
sFGR appears to occur at a similar rate in both MC and DC pregnancies at 11-12%20, but 
neurological complications are more common in affected MC than DC pregnancies21. The 
pathology of sFGR brings together the effects of unequal placental sharing, impaired 
placental function and the paradoxical effects of placental anastomoses to affect cerebral 
perfusion and development. The incidence of severe NDI in MC twins with birthweight 
discordance is reported to be as high as 42%,22 compared to DC twins with birthweight 
discordance (13%) or concordant MC twins (8%). In comparison to TTTS or TAPS, however, 
the literature is extremely limited. The most recent systematic review of NDI in sFGR found 
only five studies using such heterogenous outcomes that meta-analysis was prevented. With 
expectant management, neurologically intact survival of both twins at 6 months is reported in 
96% of Type 1 sFGR, but only 33% of Type II cases.23 In type III sFGR, 62% had intact 
neurology with expectant management.24 NDI appears to be more common in the smaller 
twin, presumably the twin more likely to have experienced placental insufficiency and 
undernutrition.25 However, the possible confounding effect of prematurity and its associated 
complications should be taken into account. Fetal therapy either by selective reduction or 
FSLC may be offered in sFGR, especially in early onset cases, but the relative effect on NDI 
and long term outcomes is under reported. Only 6 out of 39 studies evaluating treatment for 
sFGR reported any long term infant outcomes.26 Although fetoscopic intervention in sFGR is 
more technically challenging, it is of particular interest because, even though it is associated 
with a high risk of intrauterine demise (IUD) of the smaller twin, it may protect the larger twin 
from the consequences of co-twin demise without requiring cord occlusion and still afford the 
smaller twin a chance of survival.24 Consistent reporting of neurological morbidity is clearly 
essential to determining the clinical utility of interventions for sFGR. 
The perinatal event most strongly associated with NDI in MC twins is the IUD of one twin, 
followed by death of the co-twin in 15% of cases, and severe NDI in 26%.27 A key benefit of 
fetal intervention in sFGR, TAPS and TTTS is separation of the fetal circulations prior to IUD 
of a twin and thereby preventing the subsequent cerebral injury. Even in uncomplicated 
MCDA pregnancy, an excess risk of IUD compared to DC twins persists throughout the third 
trimester,28 which is often associated with acute perimortem TTTS.29 The prediction and 
prevention of these events is critical not just to improving survival but also to improving 
neurodevelopmental outcome and as yet no clear predictors have been identified.  
Conversely, selective reduction to a singleton pregnancy by cord occlusion or 
radiofrequency ablation is associated with a significantly improved neurodevelopmental 
outcome for the surviving twin compared to expectant or fetoscopic management of sFGR or 
discordant anomalies in MC twins. The incidence of NDI in the surviving twin may be as low 
as 2%,30 although the diagnosis leading to the decision to undertake selective reduction may 
affect the likelihood of NDI.31  
Challenges in evaluating long term outcomes in multiples  
A significant challenge in evaluating long term behavioural and developmental outcomes in 
twins is the fact that twins grow and develop in a social and family environment substantially 
different to that experienced by singletons. Twins exhibit speech and language delay relative 
to singletons, but also frequently develop ‘cryptoglossia’ or a ‘secret language’ the twins use 
with each other.32 Bilingual children also exhibit language delay without underlying pathology 
or alteration in quality of life33 and the observed communication delay in multiples could be 
similar, but requires further study. Alternatively, parenting multiples is a stressful life event 
that may alter the home environment, require more frequent assistance from extended 
family, reduce direct parent to child interactions or exacerbate financial strain on the 
household. Any of these factors could contribute to observed differences in multiples and 
could be considered in any long term assessment.  
The timing of assessment may impact the prevalence and nature of outcomes detected. 
Several studies have noted a particular lag in motor development in multiples in long term 
follow up to two years,14 but also that multiples seem to ‘catch up’ to their singleton peers by 
2 years of life.11 The relative lack of studies following children up to school age makes it 
difficult to assess whether this pattern could ultimately balance the inequalities between 
multiples and singletons or whether developmental and behavioural outcomes would still 
differ throughout life.  
The majority of the studies reporting NDI cited above followed children up for between 6-24 
months, and yet we know that outcomes at 2 years of age only partially predict 6 year 
outcomes. As children grow, functional outcomes across several domains increase in 
relevance, including communication and independence which are of great importance to 
parents and the children themselves.6 Those parameters most important to a child’s quality 
of life and potential for successful independent living may only be detectable at school age, 
but the more distant the assessment the more the child’s development is affected by social 
and environmental factors in addition to perinatal events (Figure 4).   
The greatest practical challenge to assessment of long term outcomes after complicated MC 
pregnancies is organising ongoing specialist review for children not living within easy reach 
of the original treatment facility. Most fetal therapy centres rightly offer treatment to patients 
from a wide geographical region, with international travel for fetoscopic intervention a 
relatively common phenomenon. There is significant variation between fetal therapy centres 
in the nature and duration of postnatal follow up for MC pregnancies which contributes to the 
lack of available data. In some cases no routine follow up occurs centrally, and in most only 
complicated or premature babies are routinely followed up, usually to 2 years of age, 
excluding those ‘uncomplicated’ MC twins.  
How should we target interventions to improve long term neurodevelopment in 
multiples? 
The long term neurodevelopment of a child is influenced by many factors, some amenable to 
perinatal intervention and others (gender, genetic make-up, socio-economic status of 
parents) that are not directly influenced by clinicians (Figure 5). In seeking to improve long 
term neurodevelopment in multiples we should start with reducing fetal morbidity, preterm 
birth and improving neonatal and infant care.  
We can act to reduce fetal morbidity, starting from the moment of conception in the case of 
pregnancies conceived after assisted reproduction. Reducing the incidence of multiple 
pregnancy associated NDI should include considered use of assisted reproductive 
technologies and clear and honest counselling of prospective parents.34 
Fetal morbidity can further be reduced by improving antenatal detection of complications, 
including improving the understanding of how MC placentation in itself affects fetal cerebral 
development and the risk of unexpected IUD or cerebral injury in an apparently 
uncomplicated MCDA pregnancy.  It is possible that the number and nature of placental 
anastomoses and its associated acute and chronic hemodynamic changes may contribute to 
adverse neurological outcomes in complicated MC twin pregnancies. However, the 
association of these hemodynamic disturbances in the donor and recipient twin and 
increased risk for adverse neurological outcomes is yet to be fully understood.  
We have seen a continuous improvement in surgical techniques in FSLC for TTTS that may 
be transferable to invasive therapy for TAPS and sFGR. The relative benefits of FSLC, 
selective reduction and delivery for TAPS and sFGR must be clarified in high quality 
prospective studies reporting the core outcomes identified for these conditions,17,35 including 
long term follow up. 
Reducing preterm birth must be the cornerstone of any strategy to reduce NDI in multiple 
pregnancy. Spontaneous preterm birth could be reduced with improved surgical techniques 
to reduce the risk of procedure related complications and preterm rupture of membranes. A 
key contributor to NDI after FSLC for TTTS is spontaneous preterm birth and as yet our 
ability to predict and prevent this is limited. Interventions including cerclage in women with a 
short cervix after FSLC or progesterone supplementation may offer benefit, but have rarely 
been reported in complicated MC pregnancies. It is important to emphasize that evidence 
derived from uncomplicated MC twin pregnancies cannot be extrapolated into complicated 
MC twin pregnancies, particularly after fetal interventions because the nature of the prenatal 
insults and natural history of each MC twin pregnancy complication is different from the 
natural history of uncomplicated MC twin pregnancies36,37. The need for iatrogenic preterm 
delivery could be reduced by the development of new therapies for sFGR and TAPS to 
prevent fetal deterioration requiring delivery. Lastly, specialist multidisciplinary management 
of MC pregnancies is recommended38 and is likely to reduce unnecessary iatrogenic preterm 
birth. Disappointingly, relatively few obstetric units in the UK provide this service at present,39 
and we call on policy makers to increase the availability of specialist multiple pregnancy 
services to benefit the long term health and wellbeing of multiples and their families.  
Once born, continuing input of clinicians with expertise in multiple pregnancy can facilitate 
both prevention and earlier intervention for NDI. Given the incidence of NDI in well MC twins, 
cranial imaging in the neonatal period should be considered in all MC infants. Treatment 
from occupational therapists, speech and language therapists and child psychologists can 
significantly improve longer term development for these children and even simple parent 
delivered behavioural interventions can be of benefit. Since even uncomplicated MC 
pregnancies are at increased risk of mild to moderate NDI, there is a strong argument for 
ensuring longer term follow up for all MC twins. Long term follow up clinics of these infants 
will facilitate crucial early interventions but also provide key long term data for refining and 
improving care of MC pregnancies in the future. Ultimately, we cannot improve long term 
neurodevelopment in multiples unless we measure it.  
Listening to patients and families as an essential research paradigm  
A sweeping call to expand long term follow up to all MC twins is certainly daunting in scope; 
with major resource and service configuration implications. Nonetheless, multiple 
stakeholder consensus projects have shown us that long term outcomes are both of great 
significance to parents17,35,40 and under reported in our existing literature.16,26 We 
acknowledge that that the key to maximising the real clinical impact of academic work is 
systematic involvement of patients and families throughout research development and 
reporting. Where an outcome is so important to the end users of research, it falls to us as 
clinicians and researchers not to dismiss it as impractical but to consider how we can alter 
our practice to answer the questions that matter to parents and families.  
These are times of great change and in these moments the opportunity to develop new and 
valuable patterns of care must be seized.41 Telemedicine in paediatric clinics has already 
been trialled42 and does not only facilitate increased access to specialist review for 
geographically dispersed patients43 but also offers the additional insights of reviewing 
children in their own homes and with their families. Why not adapt similar methods for the 
long term follow up of MC pregnancies by central fetal therapy centres? What other 
innovative tools could be developed to create family centred care to the lifelong benefit of 
these children?  
Beyond direct clinical care, we should also consider our role as advocates for our patients. 
We recognise the importance of social and economic support for the parents of multiples in 
promoting optimal development and equal life chances for children born after multiple 
pregnancies, and we call on clinicians and academics worldwide to highlight the special 
needs of these families.  
Long term neurodevelopment in MC twins is under reported, poorly understood and a 
growing public health concern. It is time to combine clinical excellence and academic rigour 
to improve outcomes that matter to families. 
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FIGURE LEGENDS 
Figure 1. Definition of cerebral palsy and neurological impairment 
Figure 2. Complications of monochorionic twin pregnancies 
Figure 3. Incidence of neurodevelopmental delay in monochorionic twins 
Figure 4. Long-term neurodevelopment outcome: Why and When? 
Figure 5. Long-term neurodevelopment outcome: Risk factors and possible interventions 
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